Brief: There will be 15% U.S. tariffs on pharma, exemption for rare diseases, Recordati CEO says
30/07/2025 13:36
July 30 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA RECI.MI CEO Robert Koremans says in post-results conference call: ITALY'S RECORDATI CEO: FROM WHAT WE HEAR THERE WILL BE 15% US TARIFF ON PHARMA PRODUCTS, RARE DISEASES ARE EXCLUDED Further company coverage: RECI.MI (Reporting by Milan Newsroom) ((cristina.carlevaro@thomsonreuters.com; +39 02 66129585;))
Recent news on Recordati Industria Chimica E Farmaceutica SpA
See all newsBrief: CVC Investor Enters Amendment To Allow Total Return Swap Derivatives In Context Of Takeover Bid On Recordati's Shares
Brief: Recordati Says Italy's Watchdog Consob Suspends Review Period For Approval Of Offer Document
Italy - Factors to watch on June 22
Brief: Respighi BidCo Files With Italy's Market Watchdog Consob Offer Document Related To Tender Offer For Recordati
Press Digest: Wall Street Journal - May 26